Renita Medical raises seed funding
Renita Medical Oy, a healthtech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.
Renita Medical is building a personalized brain health solution. The company’s AI-based software, the RENITA platform, uses a patient’s own functional brain activity and combines it with proven cognitive assessment tools to provide a comprehensive and objective report, from which doctors can base their neurological diagnosis. The platform will enhance the neurological diagnosis process and will offer an efficient way to monitor brain health.
Oaklins’ team in Finland acted as the financial advisor in this transaction.
Talk to the deal team
Related deals
Cerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreGewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.
Gewiss S.p.A. has successfully finalized a mandatory public tender offer for Beghelli S.p.A.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more